Also available in Persian — نسخه فارسی ✈️ Telegram EN فا
❓ Unknown

Study Reveals Epigenetic Pathways in Liver Tumor Formation Without Driver Mutations

1w ago October 22, 2026 1 min read 📰 Medical Xpress
📋 Key Takeaway

A study from Science Tokyo reveals that liver tumors can form through epigenetic pathways without driver gene mutations, highlighting the YAP1–TEAD–TET1 axis's role in oncogene activation. This research is significant as it provides insights into cancer development mechanisms, which may have implications for healthcare in Iran, where liver diseases are prevalent.

🔍 Quick Context Guide
💡 Bottom Line: New insights into liver cancer development could lead to innovative treatments, particularly relevant for countries like Iran with high liver disease rates.

👥 Key Players

Science Tokyo MENTIONED
Research institution
"Their research contributes to understanding cancer mechanisms, which is crucial for addressing health issues in Iran."
YAP1, TEAD, TET1 MENTIONED
Molecular pathways involved in cancer development
"Understanding these pathways can lead to new treatment strategies for liver cancer, a significant health concern in Iran."

📰 What Happened

A study found that liver tumors can develop through epigenetic mechanisms without the need for driver gene mutations. The research identified a specific molecular pathway that activates oncogenes in liver cancer.

  • The study revealed the YAP1–TEAD–TET1 axis as a key player in liver tumor formation.
  • Suppressing TET1 in mice reduced tumor formation, indicating a potential therapeutic target.

💡 Why It Matters

🇮🇷 For Iran: Liver diseases are prevalent in Iran, and understanding alternative pathways for cancer development can lead to better prevention and treatment strategies.
🌍 Regional: This research could influence cancer research and treatment protocols across the Middle East, where liver cancer is a growing concern.
🌐 International: The findings may impact global cancer research, particularly in how cancers are understood and treated without traditional genetic mutations.

📚 Background

Cancer can develop through genetic mutations or epigenetic changes, which do not alter the DNA sequence but affect gene expression. This study highlights the latter as a significant factor in liver cancer.

Cancer research Epigenetics Liver diseases
📡 Source: NEUTRAL
📊 Confidence: 70%
The study is published by a reputable research institution, suggesting a focus on scientific accuracy.

Cancers can develop through epigenetic pathways even without driver gene mutations (DGMs), according to a study from Science Tokyo. Researchers uncovered the YAP1–TEAD–TET1 axis, which triggers DNA demethylation and activates multiple oncogenes in hepatocellular carcinoma. Suppressing TET1 reduced tumor formation in mice, while analysis of human liver disease data supported the relevance of these findings. This study reveals an alternative epigenetic route to cancer development and offers new insights into DGM-negative cancers.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →